IBA Value Chain Analysis
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
This IBA Value Chain Analysis gives you a clear, structured view of how IBA creates value across support and primary activities. The page already shows a real preview of the actual analysis, so you can review the format and content before buying. Purchase the full version to get the complete ready-to-use report instantly.
Support Activities
IBA's firm infrastructure fits a regulated, capital-heavy medtech model with long project cycles and global delivery. In 2025, governance, quality systems, and compliance oversight matter because IBA must coordinate hospital, industrial, and service work across 3 customer groups and multiple markets. Strong control systems help cut delay risk and keep audits, safety, and contract delivery aligned.
IBA's HR management must secure rare physicists, engineers, software specialists, field staff, and regulatory experts, because proton therapy and dosimetry systems need deep technical skill and tight service discipline. In 2025, IBA operated in a market with 100+ proton therapy centers worldwide, so talent quality directly shapes install speed, uptime, and compliance. Retention matters because each lost expert slows delivery and raises support risk.
R&D sits at the core of IBA's value chain, from particle accelerator design to proton therapy systems, dosimetry, and sterilization. Continuous engineering lifts beam precision, improves system uptime, and tightens software integration.
That matters because proton therapy plants are large, high-cost installs, so even small gains in reliability can improve project economics and service revenue. IBA's technology base also supports recurring upgrades and application-specific customization.
Procurement
IBA's procurement team buys specialized magnets, vacuum systems, power electronics, controls, and precision mechanical parts from a narrow supplier base. That makes sourcing a key control point in the value chain, because even one weak supplier can slow delivery or raise defect risk.
Effective procurement helps IBA lock in lead times, protect quality, and keep costs stable in highly customized systems. It also supports cleaner production planning when long-lead parts drive the build schedule.
IBA's support activities are built for a regulated, high-precision medtech chain: governance, quality, talent, R&D, and sourcing all feed delivery speed and compliance. In 2025, IBA serves 100+ proton therapy centers worldwide, so small gains in reliability, staffing, and supplier control can lift uptime and lower audit risk.
| 2025 data | Signal |
|---|---|
| 100+ centers | Global support load |
| Rare skills | HR bottleneck |
| Narrow suppliers | Procurement risk |
What is included in the product
Primary Activities
IBA's inbound logistics centers on receiving long-lead, high-spec components for accelerators, treatment rooms, and dosimetry gear. Because many parts are custom-built, tight supplier coordination and quality checks are critical before assembly starts. That matters in a business where a single late or out-of-spec part can delay a full installation.
IBA's Operations turn proton therapy, dosimetry, and sterilization designs into shipped systems through engineering, assembly, software integration, and final validation. The work is project-based and high mix, so each unit needs factory build time, test cycles, and acceptance checks before delivery. In 2025, this kind of capital equipment workflow is a key driver of IBA's margin profile, since each project moves from design to install to clinical or industrial sign-off.
That makes Operations a value chain step where quality, uptime, and on-time delivery matter most.
IBA's outbound logistics is built for one-off, high-value systems that ship in modules to hospitals and industrial sites worldwide. That means staging, customs handling, site-readiness checks, and delivery sequencing all have to line up before installation starts.
With global goods trade still near $25 trillion in 2024, cross-border moves add real delay and cost risk, so IBA's logistics is a service step, not just transport.
Marketing and Sales
IBA sells through direct technical relationships, clinical proof points, and long-cycle bids to hospitals, governments, and industrial buyers. In 2025, this model still depends on installed-base credibility, since each sale often follows site-specific validation and funding approval, not fast retail-style selling. Clear economic data matters most: buyers want proof that throughput, uptime, and treatment results justify the capex.
Service
IBA's service arm covers installation support, maintenance, upgrades, remote monitoring, training, and operational help after deployment. This keeps systems running, cuts downtime, and protects customer trust. It also supports retention and helps IBA build recurring revenue from its installed base.
IBA's primary activities are project-led and capital intensive: custom engineering, factory assembly, software integration, global delivery, and lifetime service. In 2025, value creation still hinges on installed-base trust, because each sale depends on clinical proof, site readiness, and precise execution.
| Activity | Value driver |
|---|---|
| Operations | Custom build, test, validate |
| Service | Uptime, upgrades, retention |
Get Your Copy
IBA Reference Sources
You're viewing the actual IBA Value Chain Analysis document, not a sample. The preview below is taken directly from the full report, so the structure and content reflect what you'll receive after purchase. Once your order is complete, the full IBA Value Chain Analysis becomes available for download.
Frequently Asked Questions
IBA Value Chain Analysis is centered on three businesses: proton therapy, dosimetry, and sterilization. Those 3 lines share the same accelerator know-how, but they serve 2 demand pools: hospitals and industrial users. That mix favors technical differentiation, long project cycles, and recurring service follow-through for safety-critical equipment.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.